[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100468937":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":36,"responsibleParty":78,"collaborators":80,"id":83,"slug":84,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":89,"eligibilityCriteria":90,"healthyVolunteers":85,"sex":91,"minAge":92,"maxAge":20,"enrollmentInfo":93,"targetDuration":20,"studyType":96,"phases":97,"briefSummary":99,"conditions":100,"keywords":20,"overallStatus":39,"whyStopped":20,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":111},{"fullName":5,"class":6},"LeMaitre Vascular","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"LeMaitre TufTex Single Lumen Embolectomy Catheter","OTHER","The LeMaitre® Single Lumen Embolectomy Catheter is a catheter that consists of a natural latex rubber balloon secured with ligatures to a single lumen radiopaque shaft. When the balloon the emboli and\u002For thrombi can be removed by withdrawing the catheter tip through the arteriotomy.",[13],"Device: TufTex Single Lumen Embolectomy Catheter",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","TufTex Single Lumen Embolectomy Catheter","The SLC Embolectomy Catheter is indicated for the removal of arterial emboli and thrombi",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Giorgio Prouse","Ospedale Regionale di Lugano - sede Civico","PRINCIPAL_INVESTIGATOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"Andrew Hodgkinson","CONTACT","781-425-1664","ahodgkinson@lemaitre.com",{"name":33,"role":29,"phone":34,"phoneExt":20,"email":35},"Brian Orrick","7814251685","borrick@lemaitre.com",[37,52,65],{"facility":38,"status":39,"city":40,"state":20,"zip":20,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Ziekenhuis Oost-Limburg","RECRUITING","Genk","Belgium","BE",{"type":44,"coordinates":45},"Point",[46,47],5.50082,50.965,{"lat":47,"lon":46},[50],{"name":51,"role":29,"phone":20,"phoneExt":20,"email":20},"Wendy Zwinnen",{"facility":53,"status":39,"city":54,"state":20,"zip":20,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Andrej Udelnow","Brandenburg","Germany","DE",{"type":44,"coordinates":58},[59,60],6.14466,50.69716,{"lat":60,"lon":59},[63],{"name":64,"role":29,"phone":20,"phoneExt":20,"email":20},"Andrej Udelnow, MD",{"facility":23,"status":66,"city":67,"state":20,"zip":20,"country":68,"countryCode":69,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"NOT_YET_RECRUITING","Lugano","Switzerland","CH",{"type":44,"coordinates":71},[72,73],8.96004,46.01008,{"lat":73,"lon":72},[76],{"name":77,"role":29,"phone":20,"phoneExt":20,"email":20},"Giorgio Prouse, MD",{"type":79,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[81],{"name":82,"class":6},"Avania","100468937","a-pmcf-study-to-confirm-the-performance-and-safety-of-the-lemaitre-tuftex-single-lumen-embolectomy-catheter-100468937",false,"NCT05386277","A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter","A Post Market Clinical Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter on Patients Undergoing Surgical Treatment for the Removal of Arterial Emboli and\u002For Thrombi","SLC","Inclusion Criteria:\n\n1. Male and female subject, ≥ 18 years of age at time of enrollment.\n2. Subject who is scheduled to undergo surgical treatment for the removal of arterial or venous emboli and\u002For thrombi, where one of the LeMaitre® Embolectomy Catheter will be used.\n3. Subject signed an Informed Consent for participation.\n4. Subject diagnosed with a embolus\u002Fthrombus.\n5. Subjects for whom thrombolytic therapy had failed or was contraindicated.\n\nExclusion Criteria:\n\n1. Co-morbidity that in the discretion of the investigator might confound the results.\n2. Subjects who are unable to read or write.\n3. Pregnant or lactating women at time of enrollment\n4. Subjects who are immune comprised","ALL","18 Years",{"count":94,"type":95},112,"ESTIMATED","INTERVENTIONAL",[98],"NA","A post market clinical study to confirm the performance and safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter on patients undergoing surgical treatment for the removal of arterial emboli and\u002For thrombi",[101],"Arterial Thromboembolism","2024-10-16",{"date":104,"type":105},"2024-10-18","ACTUAL",{"date":107,"type":105},"2022-01-11",{"date":109,"type":95},"2027-06",{"name":5,"class":6},3]